These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 18381471

  • 1. Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service.
    Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff DF.
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):799-804. PubMed ID: 18381471
    [Abstract] [Full Text] [Related]

  • 2. Data sources for measuring colorectal endoscopy use among Medicare enrollees.
    Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff DF.
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2118-27. PubMed ID: 17932360
    [Abstract] [Full Text] [Related]

  • 3. Validation of self-reported history of colorectal cancer screening.
    Khoja S, McGregor SE, Hilsden RJ.
    Can Fam Physician; 2007 Jul; 53(7):1192-7. PubMed ID: 17872816
    [Abstract] [Full Text] [Related]

  • 4. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC, Rosenthal M, Gatsonis CG, Zheng J, Epstein AM.
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [Abstract] [Full Text] [Related]

  • 5. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ, Cai Y, Green P, Beckett LA, Franks P, Baldwin LM.
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [Abstract] [Full Text] [Related]

  • 6. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR, Grill J, Noorbaloochi S, Powell AA, Burgess DJ, Vernon SW, Halek K, Griffin JM, van Ryn M, Fisher DA.
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [Abstract] [Full Text] [Related]

  • 7. Trends in colorectal cancer test use in the medicare population, 1998-2005.
    Schenck AP, Peacock SC, Klabunde CN, Lapin P, Coan JF, Brown ML.
    Am J Prev Med; 2009 Jul; 37(1):1-7. PubMed ID: 19423273
    [Abstract] [Full Text] [Related]

  • 8. Validation of self-reported colorectal cancer (CRC) screening in a study of ethnically diverse first-degree relatives of CRC cases.
    Bastani R, Glenn BA, Maxwell AE, Ganz PA, Mojica CM, Chang LC.
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):791-8. PubMed ID: 18381469
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Barriers to colorectal cancer screening among Medicare consumers.
    Klabunde CN, Schenck AP, Davis WW.
    Am J Prev Med; 2006 Apr; 30(4):313-9. PubMed ID: 16530618
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fecal occult blood testing for colorectal cancer screening: use the finger.
    Burke CA, Tadikonda L, Machicao V.
    Am J Gastroenterol; 2001 Nov; 96(11):3175-7. PubMed ID: 11721767
    [Abstract] [Full Text] [Related]

  • 14. Increase in screening for colorectal cancer in older Americans: results from a national survey.
    Chen X, White MC, Peipins LA, Seeff LC.
    J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
    [Abstract] [Full Text] [Related]

  • 15. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
    Almog R, Ezra G, Lavi I, Rennert G, Hagoel L.
    Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
    [Abstract] [Full Text] [Related]

  • 16. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment.
    Jones RM, Mongin SJ, Lazovich D, Church TR, Yeazel MW.
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):777-84. PubMed ID: 18381476
    [Abstract] [Full Text] [Related]

  • 17. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
    Baig N, Myers RE, Turner BJ, Grana J, Rothermel T, Schlackman N, Weinberg DS.
    Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.